AON's Fred Divers, MD, explains why the network exited CMS's Enhancing Oncology Model over opaque benchmarks, data delays and shifting rules.
Business of Value
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
2
VBC Risk Is Outpacing Provider Readiness, CMS Must Act
3
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5